Clinical Trials in Detroit

Showing 11701-11720 of 16,931 trials

Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel

NCT00499694

RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Bevacizumab may also stop the growth of tumor cells by blocking blood flow to the tumor. Drugs used in chemotherapy, such as satraplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving satraplatin together with bevacizumab may kill more tumor cells. PURPOSE: This clinical trial is studying how well giving satraplatin together with bevacizumab works in treating patients with metastatic prostate cancer previously treated with docetaxel.

Prostate Cancer

Barbara Ann Karmanos Cancer Institute31 participantsStarted Oct 2007

Detroit, Michigan, United States • Detroit, Michigan, United States

TERMINATEDPhase 2< 1 mile

Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus

NCT02533570

The purpose of this study is to evaluate the safety and tolerability of brentuximab vedotin in adults with active systemic lupus erythematosus (SLE).

Systemic Lupus Erythematosus

Seagen Inc.20 participantsStarted Jul 2015

Birmingham, Alabama, United States • El Cajon, California, United States • La Palma, California, United States +14 more locations

Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel

Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus

Find Trials by Condition in Detroit

A Phase 3 Study to Evaluate the Efficacy and Safety of Ivacaftor and VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutation

MRI Study of Radiation-Induced Damage to White Matter and Blood-Brain-Barrier

Therapeutic Imaging Biomarkers for Amyotrophic Lateral Sclerosis

MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain

Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma

A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis

Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis

Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older

A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian Cancer

A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer

Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma

Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia

A Study of Tasisulam in Treating Participants With Malignant Melanoma

Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting

A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors

Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older

Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children

Evaluation of the Accuracy of an Implanted Glucose Sensor